QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications [Yahoo! Finance]
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Qiagen (NYSE: QGEN) had its price target lowered by analysts at Stifel Nicolaus from $55.00 to $45.00. They now have a "hold" rating on the stock.
Qiagen First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]